Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open study of quadrivalent VN-100 in Japanese healthy volunteers
jRCT2080222562Phase 3Completed
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Jul 2014
- Modality
- Gene Therapies
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of VN-100 in seasonal influenza, sponsored by Daiichi Sankyo Co., Ltd. Primary endpoint: Safety: serious adverse events and adverse events leading to discontinuation after second intradermal vaccination. Started Jul 2014; status: completed.
02
Drugs
VN-100
03
Conditions
seasonal influenza
Beyond the preview
Go deeper on jRCT2080222562.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222562.